Analytica Ltd (ASX:ALT) and SportsMed Global have announce a non-binding Memorandum of Understanding to pursue planning for the integration of the PeriCoach™ pelvic floor exercise system and the SportsMed system.
Analytica’s PeriCoach system is an e-health treatment system for women who suffer urinary incontinence. This affects 1 in 3 women worldwide and is usually caused by trauma to the pelvic floor muscles as a result of pregnancy, childbirth and menopause.
PeriCoach comprises a sensor device, smartphone app and a cloud database with web portals for users and their nominated clinicians.
The device evaluates activity in pelvic floor muscles and transmits muscle activity to a smartphone app. Physicians can monitor their patient’s progress via a secure web portal.
This system enables physicians to remotely determine if a woman is performing her pelvic floor exercises and if these are improving her condition.
It is the only pelvic floor exercise system that allows clinicians to manage, monitor and motivate their patients in between appointments.
The SportsMed system was originally developed in conjunction with the New Zealand Rugby Union to manage the case and cost management of its registered players.
SportsMed is now expanding internationally into US and European fitness centres, gym chains, corporate health, and fitness and wellness solutions for consumers.
Unlike other e-Health systems SportsMed athlete information is intended to be shared with a number of 3rd parties such as a physiotherapist, doctor, personal trainer or coach.
A future product in the PeriCoach product development pipeline has been the combination of pelvic floor exercise data with other factors influencing the pelvic floor such as injury, nutrition, medication, maternal history, and overall health and fitness.
Partnership with SportsMed may expedite the development of the PeriCoach crossfunctional data analysis system.
In return for rapid access to this market Analytica provides SportsMed with a unique product for their offering to female gym chains, sports teams and corporate health schemes.
Analytica recently initiated a partially underwritten rights issue to raise around $3 million at $0.03 per share.
News: Analytica to integrate pelvic floor exercise product with SportsMed
Add to My Watchlist
What is My Watchlist?